This project looks to examine the safety of the medication Pimavanserin, marketed under the brand name Nuplazid. Pimavanserin is prescribed to manage Parkinson’s Disease Psychosis, a common side effect of Parkinson Disease medications. This medication has already received regulatory approval in the United Stated by the Food and Drug Administration under a special program called […]
Read More